Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: J Immunol. 2016 Mar 21;196(9):3631–3641. doi: 10.4049/jimmunol.1501740

FIGURE 5.

FIGURE 5

iTreg directly suppress autoreactive B cells in vitro and in vivo in lupus-prone mice. (A) iTreg and CD4med cells induced from young or old BWF1 mice were co-cultured with B cells in the presence or absence of LPS for 3 days, the supernatants were harvested for measurement of IgG production by ELISA. Data were presented as the Mean ± SEM. ***p<0.001 means control CD4med cell group versus iTreg group. (B and C) iTreg or control CD4med cells induced from BWF1 mice that had developed high titers of anti-DNA and proteinuria were adoptively transferred to old lupus mice with evident lupus syndromes. These lupus mice have been previously depleted of endogenous T cells (300ug anti-mouse CD3 antibody, iv) 1 day before the cell transfer. The IgG antibody production was measured in different lupus mice groups at the 0, 1, 2 week time points after cell transfer. Data were presented as the Mean ± SEM. ***p<0.001 means CD4med cell group versus iTreg group. (D and E) iTreg or CD4med cells induced from NZM2328 mice with evident lupus syndromes were adoptively transferred to established lupus mice (16 weeks age), the anti-dsDNA IgG and proteinurina level were measured. *p<0.05, **p<0.01 means CD4med control cell group vs. iTreg group at weeks 24 and 28.